EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The N6 ‐methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression

Xiaoqing Chen, Wenli Diao, Xinyue Guo, Wenmin Cao, Yang Yang, Tianlei Xie, Wei Chen, Lin Yang, Qing Zhang iD, Meng Ding iD, Hongqian Guo iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Xiaoqing Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Adenosine, RNA-Binding Proteins, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nanjing Medical Science and technology development Foundation, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N 6 ‐methyladenosine (m 6 A) is the most abundant RNA modification in mammalian cells, and has emerged as an important player in tumour development through post‐transcriptional gene regulation. In this study, we found that the m 6 A reader protein IGF2BP3 was the most upregulated m 6 A modifier in bladder cancer through the proteomic analysis of 17 pairs of human bladder cancer tissues and adjacent normal bladder tissues, for which the expression was also positively correlated with higher tumour stage and poorer prognosis. In vitro and in vivo assays demonstrated the powerful oncogenic function of IGF2BP3 in bladder cancer. Further combined analyses of RNA‐sequencing, m 6 A‐sequencing, and RIP (RNA Binding Protein Immunoprecipitation)‐sequencing, as well as site‐directed mutagenesis assays and RIP‐qPCR identified m 6 A‐tagged HSP90AB1 mRNA as a direct target of IGF2BP3. Mechanistically, through in vitro and in vivo assays, as well as clinical sample analysis, we demonstrated that IGF2BP3 modulated the expression of HSP90AB1 in an m 6 A modification‐dependent manner, thus activating the PI3K/AKT‐signaling pathway, and promoting the development of bladder cancer. Collectively, our study highlights the critical role of the IGF2BP3‐HSP90AB1‐signaling axis in bladder cancer progression, which may serve as a promising therapeutic approach for bladder cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsAdenosineRNA-Binding ProteinsGene Expression Regulation, NeoplasticHSP90 Heat-Shock ProteinsHumansAnimalsMiceDisease ProgressionCell Line, TumorSignal TransductionFemaleMaleProto-Oncogene Proteins c-aktCell ProliferationMice, NudePhosphatidylinositol 3-KinasesPrognosisMice, Inbred BALB C

Stichwörter der Autor:innen

HSP90AB1IGF2BP3PI3K/AKT signalingbladder cancerm6A

Substanzen

AdenosineN-methyladenosineIGF2BP3 protein, humanRNA-Binding ProteinsHSP90 Heat-Shock ProteinsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Urology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, China.
  • Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology, Nanjing University, China.

ORCID-Profile: Qing Zhang, Meng Ding, Hongqian Guo

Förderung

  • Nanjing Medical Science and technology development Foundation
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Chen, X., Diao, W., Guo, X., Cao, W., Yang, Y., Xie, T., Chen, W., Yang, L., Zhang, Q., Ding, M., & Guo, H. (2025). The N6 ‐methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression. The FEBS Journal. https://doi.org/10.1111/febs.70068

Vancouver

Chen X, Diao W, Guo X, Cao W, Yang Y, Xie T, et al. The N6 ‐methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression. The FEBS Journal. 2025. doi:10.1111/febs.70068

BibTeX
@article{Chen2025,
  author = {Chen, Xiaoqing and Diao, Wenli and Guo, Xinyue and Cao, Wenmin and Yang, Yang and Xie, Tianlei and Chen, Wei and Yang, Lin and Zhang, Qing and Ding, Meng and Guo, Hongqian},
  title = {The N6 ‐methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70068}
}
Kostenlos starten →